- Home
- SGMT vs QSI Comparison
SGMT vs QSI Comparison
Compare SGMT & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMT | QSI |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.7M | 273.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMT | QSI |
|---|---|---|
| Price | $6.33 | $1.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $29.75 | $2.88 |
| AVG Volume (30 Days) | 541.5K | ★ 4.5M |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,177,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $159.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 40.20 |
| 52 Week Low | $1.73 | $0.95 |
| 52 Week High | $11.41 | $5.77 |
Technical Indicators
Market Signals| Indicator | SGMT | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 44.23 |
| Support Level | $5.95 | $1.26 |
| Resistance Level | $6.58 | $1.54 |
| Average True Range (ATR) | 0.39 | 0.09 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 28.46 | 60.00 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.